|
|
|
|
Vol. 302, Issue 3, 935-939, September 2002
Immunology Program, Lovelace Respiratory Research Institute, Albuquerque, New Mexico (R.K., S.P.S., D.K., M.L.S.); and Department of Pharmacology, University of Tennessee Health Science Center, Memphis, Tennessee (S.G.M., B.M.S.)
| |
Abstract |
|---|
|
|
|---|
Chronic exposure of rodents to nicotine via subcutaneously or
intracerebroventricularly implanted miniosmotic pumps affects T cell
function. However, this method of continuous nicotine administration does not replicate the self-motivated administration of nicotine in
human smokers. To determine whether nicotine impairs the immune system
under conditions pertinent to human smokers, we investigated the
T cell responsiveness of male Lewis rats self-administering (SA)
nicotine (0.03 mg/kg of body weight per injection) 40 to 50 times/day
for 5 weeks, using a model of virtually unlimited access to nicotine.
Compared with sham control animals, the concanavalin A-induced
proliferation of spleen cells from SA rats was significantly decreased.
Moreover, the ability of spleen cells to mobilize intracellular Ca2+ after ligation of the T cell antigen receptor (TCR)
with an anti-
TCR antibody was significantly less in SA than in
control rats. In addition, inositol 1,4,5-trisphosphate
(IP3)-sensitive intracellular Ca2+ stores were
markedly depleted in spleen cells from SA animals. These results
suggest that chronic nicotine self-administration suppresses T cell
responsiveness, and this suppression may result from an impaired
TCR-mediated signaling that stems from the depletion of
IP3-sensitive intracellular Ca2+ stores.
| |
Introduction |
|---|
|
|
|---|
Cigarette
smoking is a major health risk factor and significantly increases the
incidence of several diseases (reviewed in Sopori et al., 1994
). It is
hypothesized that this increased disease susceptibility reflects
cigarette smoke-induced changes in the immune system (Holt and Keast,
1977
). Chronic exposure to cigarette smoke suppresses a wide range of
immunological parameters in human and animal models (Sopori et al.,
1994
), and this immunosuppression is associated with the particulate
phase of cigarette smoke (Sopori et al., 1993
). Nicotine is the major
neuroactive chemical in cigarette smoke, and previous data from this
and other laboratories suggest that nicotine suppresses immune and
inflammatory responses (reviewed in Sopori, 1998
). Chronic s.c. or
i.c.v. exposure of rats to nicotine affects T cell mitogenesis and the
ability of T cells to migrate from the
G0/G1 into the S phase of
the cell cycle (Geng et al., 1996
; Singh et al., 2000
). Ligation of the
T cell antigen receptor (TCR) by anti-TCR antibodies is an in vitro
model for an antigen-induced T cell activation that stimulates protein
tyrosine kinases, leading to activation of phospholipase C-
1,
production of inositol 1,4,5-trisphosphate (IP3)
(Nishibe et al., 1990
; Robey and Allison, 1995
), and the mobilization
of intracellular Ca2+ due to
IP3. Effects of nicotine on T cell proliferation
are associated with impaired TCR-mediated signaling in T cells,
including inhibition of the ability to raise intracellular
concentration of ionized Ca2+
([Ca2+]i) (Geng et al.,
1995
, 1996
). Chronic round-the-clock exposure of rats to nicotine via
miniosmotic pumps inhibits the
[Ca2+]i response in T
cells (Geng et al., 1996
); however, it is difficult to assume that
similar changes in T cell function will occur in human smokers, who
self-administer nicotine intermittently while awake. Therefore, the
present study examined the T cell function of rats that
self-administered the drug with virtually unlimited access.
| |
Materials and Methods |
|---|
|
|
|---|
Animals. Male Lewis rats were purchased from Harlan (Indianapolis, IN), and food and water were available ad libitum.
Nicotine Self-Administration.
Self-administration was
performed according to a previously published protocol (Valentine et
al., 1997
; Fu et al., 2001
). Briefly, 7 days after acclimatization to a
reverse light cycle and handling, rats weighing 250 to 350 g were
anesthetized with an intramuscular injection of xylazine-ketamine
(13.87 mg/kg of body weight) (Parke-Davis, Morris Plains, NJ), and a
20-gauge chronic-guide cannula was stereotaxically placed bilaterally
into the paraventricular nucleus (coordinates: anterior-posterior 1.8 mm, dorsal-ventral 7.5 mm, and medial-lateral ±0.2 mm from bregma) with a flat skull (Paxinos et al., 1985
). After a recovery
period of 7 days, rats were implanted with jugular cannulae and
immediately placed into operant chambers located within individual
sound- and light-attenuating environmental enclosures. The jugular
line, exteriorized through a polyethylene button placed between the shoulder blades, was protected by a metal spring attached to the button
and connected to a dual-channel swivel outside the environmental enclosure. Rats were allowed to recover for 3 days, during which time
they received progressively higher injections of heparinized saline
(hourly injections of 50 µl containing 100-200 U/ml) and a daily
injection of 100 µl of the antibiotic enrofloxacin (Baytril; Bayer
Corporation, Shawnee Mission, KS). Following recovery, rats were
randomly assigned to a self-administering (SA) group [jugular lines
filled with nicotine (0.03 mg/kg of body weight in 200 U/ml heparinized
saline)] or a control group (heparinized saline). Rats were kept on a
12-h light/dark cycle (12:30 AM to 12:30 PM).
0.03 mg/kg of body weight) 40 to
50 times/day for 5 weeks; these animals were selected for the study.
Determination of Cotinine Levels in Blood Plasma. Blood samples were taken from animals after 20 days in the maintenance phase of nicotine self-administration, placed immediately into EDTA-containing tubes on ice, and spun at 4°C to collect the plasma. One milliliter of a plasma sample was extracted with 1 ml of sodium tetraborate (20 g/l), 3 ml of 50:50 dichloromethane/dichloroethane (Sigma-Aldrich, St. Louis, MO), and 100 ng of deuterated cotinine (Cerilliant Corporation, Austin, TX). The sample extract (lower layer of centrifuged solution) was decanted in a scintillation vial, evaporated under a gentle stream of nitrogen, and reconstituted in 1 ml of analytical-grade methanol (Fisher Scientific, Fair Lawn, NJ). Analysis was conducted by high-pressure liquid chromatography (Shimadzu SCL-10A; Shimadzu Corporation, Kyoto, Japan) coupled to a triple quadrupole mass spectrometer (API 365; Applied Biosystems, Foster City, CA). Mass spectrometry analysis was conducted in the positive ionization mode using a turbo ion spray ionization source. Parent/daughter ions for cotinine/deuterated cotinine were monitored at 177:80 and 180:80. Analyte concentrations were determined as the ratio of the compound area to the area counts of the spiked deuterated analog. Differences in the response between deuterated compounds and target analytes were compensated by creating calibration curves that spanned the range of the sample concentrations.
Preparation of Spleen Cells.
Spleen cell suspensions were
prepared as described elsewhere (Geng et al., 1995
). Briefly, spleens
were passed through stainless steel mesh, and red blood cells were
lysed by treatment with NH4Cl solution. After
washing three times with phosphate-buffered saline (PBS), cells were
suspended in complete medium (RPMI 1640 containing 10% fetal calf
serum, 2 mM glutamine, 50 mM 2-mercaptoethanol, and 10 µg/ml gentamicin).
Assay for Concanavalin A (Con A)-Induced Proliferation.
Response of spleen cells to the T cell mitogen Con A (Sigma-Aldrich)
was assayed as described previously (Geng et al., 1995
). Briefly,
5 × 105 cells were cultured in 0.2 ml of
complete medium in microtiter wells in the presence and absence of
indicated concentrations of Con A. The cultures were incubated at
37°C in the presence of 5% CO2 and harvested
after 3 days. T cell proliferation was accessed by pulsing the culture
wells with 0.5 µCi of [3H]thymidine 12 h
before harvesting.
Assay for [Ca2+]i and
IP3-Sensitive Ca2+ Stores.
[Ca2+]i was determined by
spectrofluorometry as described previously (Razani-Boroujerdi et al.,
1994
). Briefly, spleen cells were loaded with acetoxymethyl ester of
indo 1 (Sigma-Aldrich), and changes in
[Ca2+]i were recorded by
a Deltascan fluorometer (Photon Technology International, South
Brunswick, NJ). The baseline
[Ca2+]i of indo 1-loaded
cells was recorded before the addition of 2.5 µg/ml anti-rat

-TCR monoclonal antibody (mAb; BD PharMingen, San Diego, CA) and
the second antibody (Ab; 2.5 µg/ml goat anti-mouse IgG;
Sigma-Aldrich). To determine the concentration of
Ca2+ within the
IP3-sensitive Ca2+ stores,
indo 1-labeled cells were suspended in Ca2+-,
Mg2+-free PBS containing 100 µM ethylene glycol
bis(
-aminoethyl
ether)-N,N,N',N'-tetraacetic acid and treated with 1 mM thapsigargin (Sigma-Aldrich) (Kalra et al.,
2000
). The excitation wavelength for indo 1 is 355 nm, and emission was
measured at 410 and 485 nm. After subtracting the background,
[Ca2+]i was calculated as
described elsewhere (Razani-Boroujerdi et al., 1994
).
| |
Results |
|---|
|
|
|---|
Self-Administration of Nicotine Suppresses T Cell Mitogenesis.
Chronic exposure to mainstream cigarette smoke and nicotine suppresses
the ability of T cells to proliferate in response to antigens and
mitogens (Sopori and Kozak, 1998
). To determine whether chronic
self-administration of nicotine affected T cell proliferation, spleen
cells from control and nicotine SA rats were treated with Con A. Results (Fig. 1) show that nicotine
self-administration significantly decreased the ability of T cells to
proliferate at all the concentrations of Con A tested in the
experiment. Thus, self-administration of nicotine affects the
proliferative response of T cells.
|
Blood Cotinine Levels.
The half-life of nicotine in rodents is
extremely short (Mactutus, 1989
). To ascertain that the
self-administration did not produce unusually high exposures to
nicotine, plasma concentrations of cotinine, a relatively stable
(half-life > 10 h in the blood) metabolite of nicotine, were
analyzed by high-pressure liquid chromatography. Figure
2 shows that cotinine levels of nicotine SA plasma were significantly higher than those of control plasma (9.0 ± 1.5 ng/ml and 0.6 ± 0.03 ng/ml; p = 0.016). However, these concentrations are several-fold lower than the
plasma cotinine levels observed in rats constantly exposed to nicotine
(human equivalent of two packs of high-tar, high-nicotine cigarettes) for 3 to 4 weeks via the s.c. miniosmotic pumps (Geng et al., 1995
).
Thus, self-administration does not produce unphysiological nicotine
levels.
|
Self-Administration of Nicotine Inhibits Ca2+
Mobilization in Response to TCR Ligation.
Chronic exposure to
cigarette smoke (Sopori et al., 1993
) or nicotine (via the s.c. or
i.c.v. routes) (Sopori and Kozak, 1998
) impairs antigen-mediated
signaling in T cells, including Ca2+ mobilization
in response to TCR ligation (Geng et al., 1996
). To ascertain whether
chronic self-administration of nicotine also affected the
antigen-induced T cell activation pathway, spleen cells were treated
with a TCR-specific mAb and the second Ab (goat anti-mouse IgG) to
ligate TCR. This is an accepted method to simulate antigen-mediated
activation of T cells. Results from a representative experiment (Fig.
3) show that nicotine treatment strongly
inhibits the ability of T cells to raise
[Ca2+]i in response to
TCR ligation (20-30% decrease observed in the nicotine SA animals),
suggesting that self-administration of nicotine may affect the
antigen-mediated activation of T cells through inhibition of the TCR
signaling pathway at step(s) proximal to Ca2+
mobilization.
|
Nicotine Self-Administration Depletes IP3-Sensitive
Ca2+ Stores in T Cells.
Increases in cell
[Ca2+]i are dependent on
the intracellular levels of IP3. Increased
IP3 concentration triggers release of Ca2+ from IP3-sensitive
Ca2+ stores in the sarcoplasmic/endoplasmic
reticulum, which stimulates Ca2+ influx through a
capacitative action (Haverstick and Gray, 1993
). The inability of T
cells from SA animals to raise
[Ca2+]i in response to
TCR activation may result from inadequate production of
IP3 and/or inadequate levels of
Ca2+ in the IP3-sensitive
Ca2+ stores. Results presented in Fig.
4 suggest that when spleen cells are
treated with thapsigargin, an agent that primarily releases Ca2+ from IP3-sensitive
Ca2+ stores (Takemura et al., 1989
; Gouy et al.,
1990
), in a Ca2+-free medium (to discount the
effects of Ca2+ influx on
[Ca2+]i), the increase in
[Ca2+]i was substantially
lower (30-40%) in nicotine SA than in control animals. Thus, chronic
self-administration of nicotine depletes IP3-sensitive Ca2+ stores.
|
| |
Discussion |
|---|
|
|
|---|
The lungs of a two-pack smoker receive 40 to 80 mg of nicotine per
day (American Medical Association, 1986
), which translates into 0.6 to
1.2 mg of nicotine per kg of body weight per day. Daily s.c. exposure
of rats to these concentrations of nicotine for 3 to 4 weeks via
constant release miniosmotic pumps affected the antigen-mediated
signaling in T cells (Geng et al., 1995
, 1996
), indicating that chronic
administration of nicotine impairs T cell function. However, when the
same concentrations of nicotine were administered through two daily
intraperitoneal injections for 3 weeks, none of the immunological
parameters was affected (Geng et al., 1995
). Therefore, the manner in
which nicotine is administered is important in determining its effects
on the immune system. Depending on the nature of the stimulus and the
differentiation state of the T cells, signaling through TCR can lead to
profound biological responses, including activation, tolerance, and/or differentiation (Sloan-Lancaster and Allen, 1996
). Therefore, it is
essential to ascertain whether the immunological changes associated
with chronic, constant nicotine treatment reflect the effects on the
immune system that are specific to this method of nicotine
administration (i.e., constant exposure). Nicotine exposure associated
with cigarette smoking in humans is a chronic daily activity and
restricted to conscious hours. In the past, it has been difficult to
replicate this method of nicotine exposure in animals. However,
Valentine et al. (1997)
demonstrated the feasibility of chronic
nicotine self-administration in rats, and in the present study that
protocol was used to expose rats for 5 weeks to nicotine. These animals
self-administered nicotine 40 to 50 times/day, receiving 0.03 mg/kg of
body weight each time (i.e., approximately 1.2 mg of nicotine/kg of
body weight per day). This dosage is similar to the concentration that
caused functional defects in T cells of rats after 3 to 4 weeks of
exposure via miniosmotic pumps (Geng et al., 1995
, 1996
). However,
compared with the cotinine levels (>100 ng/ml) obtained through
constant nicotine exposure via miniosmotic pumps, self-administration
produced much lower plasma cotinine levels (9 ng/ml), indicating that
animals were not exposed to unusually high levels of nicotine. Despite lower plasma cotinine levels, nicotine self-administration
significantly suppressed the Con A-induced T cell mitogenesis. Because
the proliferative response to Con A is an indicator of cell-mediated
immunity, these results suggest that, as in human smokers (Sopori et
al., 1994
), self-administration of nicotine suppresses the
cell-mediated immune response. It was possible that changes in the
proliferative response reflected differences in the proportion of
splenic T cells between control and nicotine-treated animals. However,
in a previous study (Geng et al., 1995
), chronic nicotine treatment
(3-4 weeks by s.c. miniosmotic pumps) did not affect the number or the
subset distribution of lymphocytes. Therefore, it is likely that
nicotine self-administration affects the activity but not the number of T cells. It is possible that nicotine affects the responses of immune
cell types other than T cells; however, in this study we focused on the
effects of nicotine self-administration on T cell function.
The ability of T cells to increase
[Ca2+]i is an early step
in antigen-mediated T cell activation and proliferation (Weiss and Littman, 1994
). Nicotine self-administration impairs the ability of T
cells to mobilize ionized Ca2+, which is critical
for the progression of T cells from the
G0/G1 to the S phase of the
cell cycle (Clapham, 1995
; Takuwa et al., 1995
). Defects in T cell
signaling in response to Con A are also observed in T cells from human
cigarette smokers (Suzuki et al., 1999
) and rats given chronic
cigarette smoke (Kalra et al., 2000
). Our results suggest that nicotine
self-administration may affect step(s) in the T cell signaling cascade
that is/are proximal to the Ca2+ response.
Preceding the antigen-stimulated rise in
[Ca2+]i, T cells increase
the levels of IP3 through activation of
phospholipase C-
1 (Weiss and Littman, 1994
).
IP3 binds to and releases
Ca2+ from IP3-sensitive
intracellular Ca2+ stores (Clapham, 1995
). The
released Ca2+ acts in a capacitative manner to
trigger Ca2+ influx (Haverstick and Gray, 1993
),
leading to increased
[Ca2+]i. To determine the
status of the IP3-sensitive
Ca2+ stores, cells were treated in a
Ca2+-free medium with thapsigargin, which
inhibits the endoplasmic reticulum Ca2+-ATPases
(Thastrup et al., 1990
), resulting primarily in uncompensated depletion
of the IP3-sensitive Ca2+
stores (Jackson et al., 1988
). These Ca2+ stores
are critically important in the communication between the cytoplasm and
the nucleus (Greber and Gerace, 1995
; Perez-Terzic et al., 1997
).
Results presented herein suggest that self-administration of nicotine
significantly depletes these pools, and this depletion could affect the
ability of T cells to mobilize ionized Ca2+ in
response to TCR activation.
| |
Acknowledgments |
|---|
We thank Paula Bradley for critical reading of the manuscript.
| |
Footnotes |
|---|
Accepted for publication March 8, 2002.
Received for publication October 17, 2001.
This study was funded in part by National Institutes of Health Grants DA-04208 (to M.L.S.), DA-03977 (to B.M.S.), and DA-04196 (to B.M.S.).
Address correspondence to: Dr. Mohan Sopori, Immunology Program, Lovelace Respiratory Research Institute, 2425 Ridgecrest Rd., SE, Albuquerque, NM 87108. E-mail: msopori{at}lrri.org
| |
Abbreviations |
|---|
TCR, T cell antigen receptor; [Ca2+]i, intracellular ionized calcium concentration; IP3, inositol 1,4,5-trisphosphate; SA, self-administering; PBS, phosphate-buffered saline; Con A, concanavalin A; Ab, antibody; mAb, monoclonal Ab.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M.-R. Blanchet, E. Israel-Assayag, P. Daleau, M.-J. Beaulieu, and Y. Cormier Dimethyphenylpiperazinium, a nicotinic receptor agonist, downregulates inflammation in monocytes/macrophages through PI3K and PLC chronic activation Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L757 - L763. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Jankowska, P. Ponikowski, M. F. Piepoli, W. Banasiak, S. D. Anker, and P. A. Poole-Wilson Autonomic imbalance and immune activation in chronic heart failure - Pathophysiological links Cardiovasc Res, June 1, 2006; 70(3): 434 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Rubin, T. M. Hermanson, E. J. Bedrick, J. D. McDonald, S. W. Burchiel, M. D. Reed, and W. L. Sibbitt Jr. Effect of Cigarette Smoke on Autoimmunity in Murine and Human Systemic Lupus Erythematosus Toxicol. Sci., September 1, 2005; 87(1): 86 - 96. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||